In the SURMOUNT-1 trial, adults without diabetes on tirzepatide lost an average of 15-22% of body weight over 72 weeks, depending on dose
Choose injectable semaglutide if you're targeting substantial weight loss (15% or more), have already tried oral form without satisfactory results, or don't mind injections and prefer weekly dosing flexibility
Januvia is meant to be used as an ongoing treatment
Additionally, individuals with a history of eating disordersincluding anorexia nervosa, bulimia nervosa, or binge eating disorderrequire specialist evaluation, as appetite-suppressing medications may exacerbate disordered eating patterns or psychological distress related to food and body image
If your BMI is lower and you have diabetes, some insurers may approve surgery
This applies to unlicensed medicines as well as licensed ones, and your report helps build the UK's understanding of emerging medicines and their real-world safety